Enhancing autophagy in CD11c+ antigen-presenting cells as a therapeutic strategy for acute respiratory distress syndrome

Cell Rep. 2023 Aug 29;42(8):112990. doi: 10.1016/j.celrep.2023.112990. Epub 2023 Aug 16.

Abstract

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are severe clinical disorders that mainly develop from viral respiratory infections, sepsis, and chest injury. Antigen-presenting cells play a pivotal role in propagating uncontrolled inflammation and injury through the excess secretion of pro-inflammatory cytokines and recruitment of immune cells. Autophagy, a homeostatic process that involves the degradation of cellular components, is involved in many processes including lung inflammation. Here, we use a polyinosinic-polycytidylic acid (poly(I:C))-induced lung injury mouse model to mimic viral-induced ALI/ARDS and show that disruption of autophagy in macrophages exacerbates lung inflammation and injury, whereas autophagy induction attenuates this process. Therefore, induction of autophagy in macrophages can be a promising therapeutic strategy in ALI/ARDS.

Keywords: CD11c; CP: Immunology; acute respiratory distress syndrome (ARDS); antigen-presenting cells; autophagy; lung inflammation; lung injury; poly(I:C).

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acute Lung Injury*
  • Animals
  • Antigen-Presenting Cells
  • Autophagy
  • Macrophages
  • Mice
  • Poly I-C / pharmacology
  • Respiratory Distress Syndrome*

Substances

  • Poly I-C